CAS 1379573-92-8

Methyl 3-[[4-[4-(aminoiminomethyl)benzoyl]-1-piperazinyl]carbonyl]-5-[[4-(aminoiminomethyl)-1-piperazinyl]methyl]benzoate

Description:

Methyl 3-[[4-[4-(aminoiminomethyl)benzoyl]-1-piperazinyl]carbonyl]-5-[[4-(aminoiminomethyl)-1-piperazinyl]methyl]benzoate, identified by its CAS number 1379573-92-8, is a complex organic compound characterized by its multi-functional structure. It features a benzoate moiety, which is indicative of its potential as an ester, and incorporates piperazine rings that suggest possible pharmacological activity, often associated with central nervous system effects. The presence of aminoiminomethyl groups indicates potential for hydrogen bonding and reactivity, which may enhance its biological interactions. This compound is likely to exhibit moderate to high solubility in polar solvents due to its functional groups, and it may participate in various chemical reactions, including acylation and nucleophilic substitutions. Its intricate structure suggests potential applications in medicinal chemistry, particularly in the development of therapeutic agents targeting specific biological pathways. However, detailed studies on its pharmacokinetics, toxicity, and efficacy would be necessary to fully understand its properties and potential uses in drug development.

Formula: C₂₇H₃₄N₈O₄

InChI: InChI=1S/C27H34N8O4/c1-39-26(38)22-15-18(17-32-6-8-35(9-7-32)27(30)31)14-21(16-22)25(37)34-12-10-33(11-13-34)24(36)20-4-2-19(3-5-20)23(28)29/h2-5,14-16H,6-13,17H2,1H3,(H3,28,29)(H3,30,31)

InChI key: InChIKey=IBVRETRIDAQSEM-UHFFFAOYSA-N

SMILES: C(=O)(C1=CC(CN2CCN(C(=N)N)CC2)=CC(C(OC)=O)=C1)N3CCN(C(=O)C4=CC=C(C(=N)N)C=C4)CC3

Synonyms:

• CBB 1007
• LSD 1 inhibitor III CBB1007
• Benzoic acid, 3-[[4-[4-(aminoiminomethyl)benzoyl]-1-piperazinyl]carbonyl]-5-[[4-(aminoiminomethyl)-1-piperazinyl]methyl]-, methyl ester
• Methyl 3-[[4-[4-(aminoiminomethyl)benzoyl]-1-piperazinyl]carbonyl]-5-[[4-(aminoiminomethyl)-1-piperazinyl]methyl]benzoate

CBB1007

CAS: 1379573-92-8

CBB1007 is a molecule that has been shown to inhibit the methylation and acetylation of lysine residues in proteins, which may be a potential biomarker for cancer. CBB1007 and its derivatives are being investigated as possible inhibitors of protein modification or as anticancer agents. In addition, CBB1007 has been shown to have anti-proliferative effects on cultured cells by inhibiting growth factor signaling pathways. This drug also inhibits tumor cell growth by inducing hypertrophy in the cells and up-regulating genes involved in cell cycle arrest.

Formula: C₂₇H₃₄N₈O₄

Purity: Min. 95%

Molecular weight: 534.6 g/mol

Ref: 3D-EFC57392

CBB1007

CAS: 1379573-92-8

CBB1007 is a potent, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1).

Formula: C₂₇H₃₄N₈O₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 534.61

Ref: TM-T10699L